Bloodborne Pathogens Standard, 29 CFR 1910.1030

1
Bloodborne Pathogens Standard, 29 CFR 1910.1030

• NJ Department of Health and Senior Services
• PEOSH Program
• [phone]

2
Bloodborne Pathogens Standard

• 29 CFR 1910.1030, Occupational Exposure to
  Bloodborne Pathogens
• Published December 1991
• Effective March 1992 (Private Employers)
• Adopted Under NJ PEOSHA July 1993
• Scope
• ALL with occupational exposure to blood and other
  potentially infectious material (OPIM)

3
Routes of Exposure

• Exposure incident means a specific contact with
  blood or OPIM through
• Cuts, Cracks or Abrasions in the Skin
• Splashing or Spraying of Blood or OPIM in the
  Eyes, Mouth, or Nose
• Puncture Wounds from Contaminated Sharps
  (needles, broken glass, or other medical devices)

4
Methods of Compliance

• Universal Precautions
• Engineering and Work Practice Controls
• Personal protective equipment
• Housekeeping

5
Universal Precautions

• An infection control concept that requires all
  blood and OPIM to be handled as if it were
  infected with bloodborne pathogens.

6
Work Practice Controls

• Wash Hands Immediately After Glove Removal
• Decontaminate Equipment Before Servicing
• Use labeled or Color-Coded Bio Hazard Containers
• Do Not Eat, Drink, Smoke, etc. in Work Areas
• Do Not Recap, Bend or Break Needles

7
Exposure Control Plan

• Written plan to eliminate or minimize exposures
  to bloodborne pathogens
• List job classifications at risk (exposure
  determination)
• ID procedures in which occupational exposure can
  occur
• Explain how the Standard will be complied with
• How employees will be protected
• How employees will be trained
• Person to contact if an exposure occurs

8
Hepatitis B Vaccination

• Made available to employees after training and
  within 10 working days of initial assignment
• A declination form must be signed if vaccination
  is refused by the employee
• Post-exposure follow-up is required to be
  provided to an employee after an exposure incident

9
Hepatitis B Vaccination

• Current Recommendations
• For HCP who are in contact with patients and/or
  blood and continues to be at risk for
  percutaneous exposure, they must be
• tested 1-2 months after completion of the
  vaccination for antibody titer.
• Source CDC, MMWR, June 29, 2001/Vol.50/No. RR-11

10
Hepatitis B Vaccine

• 3 Dose Series
• How long the protective effect in healthy adults
  last is unknown at present currently no booster
  is required.

11
Bloodborne Pathogens Standard, 29 CFR 1910.1030

• Review of Facility-Specific Exposure Control Plan
• Additional Question and Answer Period